Stablix Therapeutics

Stablix Therapeutics

  • Founded: 2020
  • Location: New York, NY
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Rare diseases
  • Drug types: RAR, ONC, IMM
  • Lead product: Restoracs
  • Product link:
  • Funding: $63M A Jun 2021
  • Investors: Versant Ventures, NEA, Cormorant, Euclidean Capital, Alexandria Real Estate Equities

job board

Short description:

Small Molecules

Drug notes:

Also RD oncology, RD immunological disorders

Long description:

Contact us to add description:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy